KZIA
Kazia Therapeutics Limited NASDAQ Listed Jan 6, 1999$9.30
-1.74%
vs $9.47
Mkt Cap $15.1M
52w Low $4.86
35.4% of range
52w High $17.40
50d MA $12.21
200d MA $10.47
P/E (TTM)
—
EV/EBITDA
—
P/B
—
Debt/Equity
-0.1x
ROE
—
P/FCF
-0.8x
RSI (14)
32.20
ATR (14)
$0.72
Beta
1.62
50d MA
$12.21
200d MA
$10.47
Avg Volume
340.5K
Kazia Therapeutics Limited, an oncology-focused biotechnology company, develops anti-cancer drugs. Its lead development candidate is Paxalisib, a small molecule, brain-penetrant inhibitor of the PI3K/Akt/mTor pathway, which is developed as a potential therapy for glioblastoma. It is also developing EVT801, an investigational new drug for various forms of cancer. The company was formerly known as Novogen Limited and changed its name to Kazia Therapeutics Limited in November 2017. Kazia Therapeutics Limited was incorporated in 1994 and is based in Sydney, Australia.
Three International Towers · Sydney, NSW 2000 · AU
| Date | Time | Est | Rptd | Surp | Base | Gap% | D1% | D2% | D3% | D4% | D5% | Guide ▲★ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Mar 16, 2026 | AMC | -0.01 | -0.41 | -5760.4% | 8.11 | +2.3% | -7.2% | -0.3% | +5.3% | -5.4% | -4.8% | — |
| Jun 30, 2025 | AMC | -0.01 | -4.18 | -9999.0% | 6.27 | -2.6% | +5.7% | -0.8% | +2.6% | -3.0% | +4.3% | — |
| May 28, 2025 | AMC | -10.76 | -7.61 | +29.3% | 3.56 | -0.3% | +6.2% | +0.5% | -0.5% | +26.7% | +11.9% | — |
| Nov 19, 2024 | AMC | -15.00 | -20.81 | -38.8% | 28.55 | -0.7% | -1.8% | -1.4% | +4.2% | -4.7% | +1.6% | — |
| Mar 27, 2024 | AMC | — | -12.53 | — | 15.69 | -7.6% | -1.3% | +4.9% | +1.4% | +2.2% | -1.1% | — |
| Nov 27, 2023 | AMC | -1.66 | -10.02 | -504.8% | 29.90 | +10.4% | +7.0% | -6.3% | -6.4% | -19.6% | -0.7% | — |
| Mar 9, 2023 | AMC | -24.65 | -31.86 | -29.3% | 50.88 | -0.7% | -1.7% | -2.0% | +3.1% | -7.0% | +3.0% | — |
| Date | Firm | Action | Grade | Target | Base | Open | Gap% | D1% | D2% | D3% | D4% | D5% |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Aug 13 | Canaccord Genuity | Initiates | Buy | $29 | $12.79 | $13.39 | +4.7% | +3.3% | +2.3% | +0.3% | +6.0% | -2.2% |
| Jul 1 | BTIG Research | Initiates | Buy | $34 | $14.08 | $14.78 | +5.0% | -4.9% | -1.0% | -1.3% | +0.2% | -4.9% |
| Jun 11 | Lake Street | Initiates | Buy | $32 | $11.50 | $12.07 | +5.0% | +9.0% | +13.9% | -1.4% | -2.2% | +3.5% |
| Jan 28 | HC Wainwright & Co. | Maintains | Buy → Buy | — | $7.15 | $7.16 | +0.1% | -8.3% | -7.0% | -3.9% | +5.8% | -2.3% |
| Dec 12 | HC Wainwright & Co. | Maintains | Buy → Buy | — | $13.08 | $13.54 | +3.5% | -20.3% | -8.8% | +5.0% | -8.8% | +9.6% |
| Oct 2 | Maxim Group | Maintains | Buy → Buy | — | $6.85 | $6.84 | -0.1% | -7.9% | +4.0% | +3.4% | +5.3% | +0.3% |
| Jul 10 | HC Wainwright & Co. | Maintains | Buy → Buy | — | $9.53 | $8.90 | -6.6% | +8.7% | +4.2% | +5.8% | -5.5% | -5.6% |
| Jun 11 | Maxim Group | Maintains | Buy → Buy | — | $5.26 | $10.50 | +99.6% | +81.4% | +2.6% | -5.0% | -2.7% | +3.1% |
| Jul 12 | HC Wainwright & Co. | Maintains | Buy → Buy | — | $62.00 | $53.50 | -13.7% | -27.8% | -37.7% | +2.6% | +15.1% | -9.9% |
| Apr 11 | HC Wainwright & Co. | Upgrade | Neutral → Buy | — | $54.50 | $57.50 | +5.5% | +6.4% | +2.6% | +1.7% | +9.1% | +2.3% |
| Aug 2 | HC Wainwright & Co. | Downgrade | Buy → Neutral | — | $96.00 | $91.00 | -5.2% | -2.6% | -5.9% | +0.9% | +4.8% | -3.2% |
| Aug 2 | Maxim Group | Downgrade | Buy → Hold | — | $96.00 | $91.00 | -5.2% | -2.6% | -5.9% | +0.9% | +4.8% | -3.2% |
| Oct 14 | Maxim Group | Maintains | Buy → Buy | — | $535.50 | $555.50 | +3.7% | -1.9% | -0.1% | -0.2% | +3.0% | -0.9% |
| Jan 5 | HC Wainwright & Co. | Maintains | Buy → Buy | — | $449.00 | $490.00 | +9.1% | +7.7% | -4.4% | +5.7% | +2.3% | +3.0% |
No insider trades available.
No recent filings available.
Institutional (13F) — Top 20
All ↗
| # | Manager | Shares | Value | Chg | Period |
|---|---|---|---|---|---|
| 1 | Dauntless Investment Group, Llc | 354,208 | $5M | Added | Jun 2026 |
| 2 | Point72 Asset Management, L.p. | 200,300 | $2M | — | Jun 2026 |
| 3 | Millennium Management Llc | 101,376 | $1M | New | Jun 2026 |
| 4 | Flputnam Investment Management Co | 142,469 | $1M | New | Mar 2026 |
| 5 | Citadel Advisors Llc | 57,018 | $803K | New | Jun 2026 |
| 6 | Cooperman Leon G | 50,000 | $704K | New | Jun 2026 |
| 7 | Westside Investment Management, Inc. | 47,585 | $670K | Reduced | Jun 2026 |
| 8 | Sequoia Financial Advisors, Llc | 20,003 | $282K | Reduced | Jun 2026 |
| 9 | Royal Bank Of Canada | 34,340 | $255K | Reduced | Mar 2026 |
| 10 | United Bank | 12,851 | $181K | New | Jun 2026 |
| 11 | Barclays Plc | 23,999 | $179K | — | Mar 2026 |
| 12 | Raymond James Financial Inc | 15,749 | $117K | New | Mar 2026 |
| 13 | Ubs Group Ag | 13,934 | $104K | Added | Mar 2026 |
| 14 | Rockefeller Capital Management L.p. | 12,700 | $94K | Added | Mar 2026 |
| 15 | Qube Research & Technologies Ltd | 10,608 | $79K | New | Mar 2026 |
| 16 | Gamma Investing Llc | 1,926 | $27K | Added | Jun 2026 |
| 17 | Rhumbline Advisers | 1,296 | $18K | New | Jun 2026 |
| 18 | Morgan Stanley | 2,000 | $14K | Added | Dec 2025 |
| 19 | Bnp Paribas Financial Markets | 1,081 | $8K | New | Mar 2026 |
| 20 | Arax Advisory Partners | 87 | $1K | New | Jun 2026 |
Mutual Funds / ETFs (N-PORT) — Top 2
All ↗
| # | Fund | Shares | Value | Period |
|---|---|---|---|---|
| 1 | Fidelity Nasdaq Composite Index Fund | 196 | $2K | Feb 2026 |
| 2 | Blackstone Alternative Multi-Strategy Fund | -300 | $-4224 | Jun 2026 |
Valuation
Market Cap
$15.1M
Enterprise Value
$6.0M
P/E (TTM)
—
Forward P/E
—
PEG Ratio
0.01x
P/B
—
P/S
4.04x
P/FCF
-0.78x
EV/EBITDA
—
Shares Out
1.1M
Financials (TTM)
Revenue
$2.5M
Net Income
-$50.7M
EBITDA
-$45.2M
Free Cash Flow
-$13.3M
Op Cash Flow
-$13.3M
EPS Basic
$-18.90
EPS Diluted
$-47.70
EPS Forward
$-1.54
Gross Margin
100.0%
Op Margin
—
Net Margin
—
Balance Sheet
Total Assets
$6.1M
Total Liab.
$14.4M
Total Equity
-$8.3M
Cash
$4.3M
LT Debt
$0
Book Value/Sh
$-7.58
Debt/Equity
-0.05x
Current Ratio
0.35
Quick Ratio
0.35
Returns & Growth
ROE
—
ROA
—
ROIC
172.6%
Rev Growth YoY
-98.2%
EPS Growth YoY
+65.6%
Price Returns
2W
-12.8%
1M
-24.9%
3M
-28.5%
6M
+29.0%
12M
+50.1%
Technicals
52W High
$17.40
52W Low
$4.86
50d MA
$12.21
200d MA
$10.47
RSI (14)
32.20
ATR (14)
$0.72
Beta
1.62
Avg Volume
341K
Dividends
Div Rate
$0.00
Div Yield
—
Frequency
—
Ex-Div Date
—
Analyst Price Targets
Consensus
$21.50
High
$25.00
Low
$18.00
Median
$21.50
Data updated apr 26, 2026 11:18am
· Source: financialmodelingprep.com